Related Experiment Video
Updated: Jul 31, 2025
04:10
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
Published on: July 19, 2024
707
Resectability in bronchogenic carcinoma: A single‑center experience
Mohammed Mowafaq Marie1, Sabah N Jaber2, Okba F Ahmed3
1Department of Surgery, Al Jamhori Teaching Hospital, Mousl 41001, Republic of Iraq.
Oncology Letters
|May 8, 2023
Summary
This study analyzed 800 bronchogenic carcinoma patients, finding it affects all sexes and is linked to smoking. Advanced staging is needed to improve lung cancer resectability rates.
Area of Science:
- Oncology
- Pulmonology
- Surgical Oncology
Background:
- Bronchogenic carcinoma is the most common primary lung tumor.
- Understanding patient demographics and cancer resectability is crucial for effective treatment strategies.
Purpose of the Study:
- To profile patients diagnosed with bronchogenic carcinoma.
- To assess the resectability of lung cancer in newly diagnosed individuals.
Main Methods:
- Retrospective review of 800 bronchogenic carcinoma patients over 5 years.
- Diagnosis confirmed via cytology, histopathology, sputum analysis, pleural effusion analysis, and bronchoscopy.
- Surgical procedures included lobectomy and pneumonectomy.
Main Results:
- Mean patient age was 62.95 years, with males predominant. Most patients were smokers or ex-smokers.
- Cough and dyspnea were the most common symptoms. Non-small cell lung cancer (NSCLC) accounted for 95.25% of cases.
- Lobectomy was the primary surgical intervention; 5 patients had postoperative complications with no mortality.
Conclusions:
- Bronchogenic carcinoma incidence is increasing in the Iraqi population, affecting both sexes.
- Effective preoperative staging and advanced diagnostic tools are essential to enhance lung cancer resectability rates.
